上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1311Please respect copyright.PENANAUt6TDHoaOk
1311Please respect copyright.PENANA5icAZg4Drj
上集:https://www.penana.com/article/4711251311Please respect copyright.PENANA6ddQqsNO41
1311Please respect copyright.PENANA8MmqER65Gl1311Please respect copyright.PENANAnGwJnbHn3v
1311Please respect copyright.PENANAS1UdP8vqx7
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1311Please respect copyright.PENANAAXTDt8j4di
1311Please respect copyright.PENANAxR3vZDPh00
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1311Please respect copyright.PENANA1DI8RTEjH1
1311Please respect copyright.PENANAsDeN02N8Pa
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1311Please respect copyright.PENANA2mpqY8SdIC
1311Please respect copyright.PENANA6uAkcoDm671311Please respect copyright.PENANAc1LV1DcrFJ
1311Please respect copyright.PENANAvMaodDrIWs
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1311Please respect copyright.PENANAtPuV2Tolx1
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1311Please respect copyright.PENANA9vZvQeh5qI
1311Please respect copyright.PENANAkwNOlSNMA2
忘記甚麼是Neoantigen的話,可重溫上一集。1311Please respect copyright.PENANAvK9FtFzsw6
1311Please respect copyright.PENANAVV54NRBCjH
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1311Please respect copyright.PENANAzdzE6atRbK
1311Please respect copyright.PENANA5OeE4291LO
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1311Please respect copyright.PENANA64yylha8MT
1311Please respect copyright.PENANAaoR99zZjmp1311Please respect copyright.PENANAhYYLP0Bq6w
1311Please respect copyright.PENANAtSkgnOX4Jt
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1311Please respect copyright.PENANAm5L85vtiWb
1311Please respect copyright.PENANAg2WNB2ArdH
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1311Please respect copyright.PENANAOjYK8cJb1T
1311Please respect copyright.PENANAcQvAVE45Eq
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1311Please respect copyright.PENANAmLeCuMg3B21311Please respect copyright.PENANASLzrl6NW7c
1311Please respect copyright.PENANA8sXsCSKujo
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1311Please respect copyright.PENANAeTEfKHUf1U
1311Please respect copyright.PENANAuYZ5f7Q5Ew
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1311Please respect copyright.PENANAzMdDHbfD6C1311Please respect copyright.PENANA2URhjBc6BF
1311Please respect copyright.PENANANYCRl2JKNA
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1311Please respect copyright.PENANAhFY7CEXBHc
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1311Please respect copyright.PENANAF7B8egMN2V
1311Please respect copyright.PENANAmJsjVo3npi
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1311Please respect copyright.PENANAMI6nx4vXR6
1311Please respect copyright.PENANABgcqx7rxZU
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1311Please respect copyright.PENANAHAOLNNhmSS
1311Please respect copyright.PENANAHkphm1Q2mu
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1311Please respect copyright.PENANAwXoSCUoA4Q
1311Please respect copyright.PENANAy1obglZ15b
1311Please respect copyright.PENANABRuusUXMp7
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1311Please respect copyright.PENANA6C1aqP93yA
1311Please respect copyright.PENANA4afAnCm7Nm
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1311Please respect copyright.PENANAptJdaTkgKi
1311Please respect copyright.PENANAGKiUWMfsEA
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1311Please respect copyright.PENANAIUHgPUjRkF
1311Please respect copyright.PENANAaQMqCvQoUE
Link:1311Please respect copyright.PENANA7dVYM1ooQy
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1311Please respect copyright.PENANAWnoX4KMrIZ
1311Please respect copyright.PENANAXSmUOFefPg
1311Please respect copyright.PENANA5OLGtW7pxT
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1311Please respect copyright.PENANATFQby27qD7